Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Executive Perspectives
Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
Panelists discuss how Project Optimus is reshaping dose selection, FDA expectations, trial designs, and cost.
FierceBiotech Staff
Dec 15, 2025 12:00am
The Role of the CMO in BD and M&A Partnering with Pharma
Dec 12, 2025 12:00am
Building Up a CMO Team as Your Company Evolves
Dec 1, 2025 12:00am
Understanding the Immunological Effects of Radiopharmaceuticals
Nov 24, 2025 12:00am
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
Nov 17, 2025 12:00am
What to Expect at the 2026 IO360° Summit
Nov 12, 2025 12:00am
